Veru Provides FDA Update on Request for Emergency Use Authorization for Sabizabulin for Hospitalized COVID-19 Patients at High Risk for ARDS
ソース:
Nasdaq GlobeNewswire
/
02 3 2023 16:01:00 America/New_York
N/A
シェアする